In This SectionTexas Health Research & Education Institute
Disease or Condition
A prospective study for the assessment of recurrence risk in stage II colon cancer patients using ColoPrint (Colon Cancer)
To validate the performance of ColoPrint in estimating the 3-year relapse rate in patients with stage II colon cancer.
Age = 18 years.
Adenocarcinoma of the colon (Note - patients with rectal cancer are not eligible).
Stage II or III, planned to be treated with radical surgery.
As stage is not determined at the time the tumor sample is taken, all samples from colon cancer patients (without signs of locally advanced disease or distant metastasis) can be sent in. Radical surgery typically refers to the removal of tumor and relevant ancillary lymph nodes.
Fresh tumor sample placed in RNA-retain with shipment at room temperature (not fixed in formalin).
Written informed consent.
Prior malignancy (with the exception of basal cell carcinoma or cervical dysplasia).